Ferdinandus, J., Kaul, H., Moccia, A., Greil, R., Hertzberg, M., Schaub, V., Hüttmann, A., Keil, F., Dierlamm, J., Hänel, M., Novak, U., Meissner, J., Hellmuth, J., Mathas, S., Zijlstra, J., Fosså, A., Viardot, A., Martin, S., Giri, P., Kamper, P., Molin, D., Jablonski, J., Fuchs, M., Rosenwald, A., Klapper, W., Eich, H., Baues, C., Dietlein, M., Kobe, C., Tresckow, B. V., Borchmann, P. (2025). Final analysis of the Phase III GHSG HD21 trial: PET-guided brecadd vs. ebeacopp in advanced-stage classical Hodgkin lymphoma. Blood. https://doi.org/10.1182/blood-2025-152